Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Consolidated Statements of Operations (Unaudited) | ||||
| Revenue, services | $ 1,218,962 | $ 2,062,603 | $ 2,778,700 | $ 3,859,198 |
| Revenue, product sales | 278,593 | 1,085,606 | 585,720 | 2,100,954 |
| Total Revenue | 1,497,555 | 3,148,209 | 3,364,420 | 5,960,152 |
| Cost of revenue, services | 731,179 | 1,074,065 | 1,635,548 | 2,086,349 |
| Cost of revenue, product sales | 34,373 | 135,867 | 78,734 | 228,406 |
| Total cost of revenue | 765,552 | 1,209,932 | 1,714,282 | 2,314,755 |
| Gross profit | 732,003 | 1,938,277 | 1,650,138 | 3,645,397 |
| Operating expenses | ||||
| Selling, general and administrative | 1,142,648 | 2,066,796 | 2,463,434 | 4,288,142 |
| Professional fees | 554,863 | 345,741 | 985,567 | 583,646 |
| Acquisition costs | 0 | 32,263 | 0 | 65,673 |
| Total operating expenses | 1,697,511 | 2,444,800 | 3,449,001 | 4,937,461 |
| Loss from operations | (965,508) | (506,523) | (1,798,863) | (1,292,064) |
| Other income (expense) | ||||
| Equity method income (loss) | 0 | (142) | 2,098 | 767 |
| Dividend income | 3,300 | 7,671 | 5,523 | 9,921 |
| Interest income (expense), net | (408,196) | (72,602) | (1,381,946) | (173,322) |
| Change in fair value of contingent consideration | (13,435) | 16,539 | (20,107) | 70,712 |
| Change in fair value of digital assets | (280,685) | 0 | (954,842) | 0 |
| Change in fair value of derivative liabilities | (2,948,217) | 0 | (3,019,609) | 0 |
| Impairment of equity and cost method investment | 0 | 0 | (129,007) | 0 |
| Gain on sale of subsidiary assets | 0 | 0 | 107,794 | 0 |
| Other income | 10,190 | 20,746 | 13,797 | 25,729 |
| Total other expense, net | (3,637,043) | (27,788) | (5,376,299) | (66,193) |
| Loss before income taxes | (4,602,551) | (534,311) | (7,175,162) | (1,358,257) |
| Income tax (provision) benefit | 0 | (128) | 0 | 17,390 |
| Net loss | (4,602,551) | (534,439) | (7,175,162) | (1,340,867) |
| Net (income) loss attributable to noncontrolling interest | 62,856 | (35,165) | 114,348 | (23,124) |
| Net loss attributable to Onfolio Holdings Inc. | (4,539,695) | (569,604) | (7,060,814) | (1,363,991) |
| Preferred Dividends | (127,095) | (95,930) | (254,155) | (199,851) |
| Net loss to common shareholders | $ (4,666,790) | $ (665,534) | $ (7,314,969) | $ (1,563,842) |
| Net loss per common shareholder | ||||
| Basic and diluted | $ (35.57) | $ (6.49) | $ (58.86) | $ (15.25) |
| Weighted average shares outstanding | ||||
| Basic and diluted | 131,207 | 102,548 | 124,274 | 102,548 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of capitalized acquisition cost incurred during period and excluded from amortization for oil- and gas-producing activities accounted for under full cost method. Excludes exploration and development costs and capitalized interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as operating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after discount, accretion and premium amortization, of interest income and dividend income classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|